April 16, 2025

Are Vision Outcomes Affected by Race in Ranibizumab Treatment for DME?

The 24-month endpoint evaluated BCVA and ETDRS letter gains

Conexiant

April 14, 2025

Macular Thickness as a Noninvasive Biomarker for Postoperative Delirium

Interocular asymmetry in retinal structure is common and may be influenced by hemispheric differences in neurodegeneration.

Conexiant

April 09, 2025

Port Delivery System With Ranibizumab for Diabetic Eye Disease

Researchers determined that the PDS may decrease the treatment burden of frequent intravitreal injections, but further research on efficacy and safety is needed.

Conexiant

April 02, 2025

GLP-1 RAs Evaluated for Long-Term Risk of NAION in Patients With Diabetes

Researchers’ subgroup analyses provide data on increased risks according to timepoint, demographics, and comorbidities.

Conexiant

April 02, 2025

Study Updates Diabetic Retinal Disease Prevalence and Incidence Data

The most recent studies on this data are at least 15 years old and do not reflect the changing landscape of treatments and technology

Conexiant

March 31, 2025

Opthea Suspends ShORe, COAST Trials

Top-line data from the phase 3 trials of sozinibercept showed that the nAMD treatment failed to meet its primary BCVA endpoints in both studies.

Conexiant

March 27, 2025

PPARG Shows Promise for Diabetic Retinopathy

The protective effect of PPARG on background diabetic retinopathy and proliferative diabetic retinopathy was largely mediated by glucose control.

Conexiant

January 01, 2024

Quick Hits: Ophthalmology News From January 2024

The latest news in ophthalmology

Ophthalmology Management

August 22, 2024

Vitamin D Deficiency May Drive RVO

“There is a complex interplay of risk factors associated with retinal vein occlusion."

Conexiant